Skip to main content
Figure 4 | BMC Cardiovascular Disorders

Figure 4

From: Treatment with the C5a receptor antagonist ADC-1004 reduces myocardial infarction in a porcine ischemia-reperfusion model

Figure 4

Plasma concentration of ADC-1004. (A) Plasma concentration over the entire experimental period. ADC-1004 was administered 20 minutes prior to reperfusion, marked by the dashed line. (B) Plasma concentration at sacrifice. The dashed line marks the desired level of ADC1004, a concentration that blocks 75% of the C5a receptors on the neutrophils. This level of blockage is considered to be therapeutic.

Back to article page